Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Cholangiocarcinoma × Chloroquine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 Gastrointestinal 1 CNS 1

Conditions

Glioblastoma 4 Small Cell Lung Carcinoma 2 Breast Neoplasms 2 Pancreatic Neoplasms 1 Pancreatic Cancer Metastatic 1 Neoplasms, Plasma Cell 1 Neoplasms 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Lung Neoplasms 1 Gliosarcoma 1 Glioma 1 Chondrosarcoma 1 Cholangiocarcinoma 1 Carcinoma, Intraductal, Noninfiltrating 1 Brain Neoplasms 1 Arthritis, Rheumatoid 1

Interventions

Gemcitabine 109 Cisplatin 74 Oxaliplatin 45 pembrolizumab 34 Fluorouracil 32 Capecitabine 31 lenvatinib 26 durvalumab 26 Leucovorin 26 Magnetic Resonance Spectroscopy 14 Irinotecan 13 Drug Therapy 13 Nivolumab 12 Biopsy 12 Albumin-Bound Paclitaxel 12 Specimen Handling 11 Radiofrequency Ablation 11 130-nm albumin-bound paclitaxel 11 tislelizumab 10 pemigatinib 10 apatinib 10 Taxes 10 Radiotherapy 10 Floxuridine 10 Bevacizumab 9 Photochemotherapy 8 Liver Transplantation 8 Folfox protocol 8 Cholangiopancreatography, Endoscopic Retrograde 8 Carboplatin 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02496741 2020-01-09

MACIST

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Phase 1/2 Completed

CNSGastrointestinalSarcoma

Chondrosarcoma, Glioma, Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡